PRELP negatively regulates IL-17A-mediated proliferation and the inflammatory response in psoriasis

Cong-cong He, Ming-xing Lei, Jing-wei Jiang, Tao Zhang, Yu-ping Lai, Rui-qun Qi, Xing-Hua Gao · 2026

Read PRELP negatively regulates IL-17A-mediated proliferation and the inflammatory response in psoriasis by Cong-cong He, Ming-xing Lei, Jing-wei Jiang, Tao Zhang, Yu-ping Lai, Rui-qun Qi, Xing-Hua Gao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13216575.txt.

Description

Cong-cong He and co-authors present a 2026 study of a matrix protein called PRELP that turns out to brake the inflammatory circuit driving psoriasis. The skin disease is powered by the cytokine IL-17A, and PRELP levels in lesions are oddly low.

Data mining showed PRELP scarce in untreated lesions but rebounding after IL-17A-blocking drugs. Experiments explained why: IL-17A itself suppresses PRELP in skin cells through the STAT3 factor. Restoring PRELP slowed skin cell growth, encouraged their death, damped inflammatory pathways, and cut IL-6 output, which in turn lowered local IL-17A production. Delivering PRELP to mouse skin eased psoriasis-like changes. The authors propose raising PRELP as a new treatment angle for Th17-driven disease.

Catalog record

CREATORCong-cong He, Ming-xing Lei, Jing-wei Jiang, Tao Zhang, Yu-ping Lai, Rui-qun Qi, Xing-Hua Gao
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13216575

Browse the full library · About the Tower of Babel